Epizyme (EPZM) Tops Q3 EPS by 3c

Epizyme (NASDAQ: EPZM) reported Q3 EPS of ($0.56), $0.03 better than the analyst estimate of ($0.59). Revenue for the quarter came in at $358 thousand versus the consensus estimate of $5.42 million.

For earnings history and earnings-related data on Epizyme (EPZM) click here.

You May Also Be Interested In

• SanDisk and Micron surge as Apple confirms memory price pass-through
• JPMorgan Upgrades SHIFT UP Corp (462870:KS) to Overweight
• Air France-KLM (AF:FP) (AFLYY) PT Raised to EUR13.50 at UBS